Company: QXO-PB
Filing Date: 2025-02-25
Form Type: DFAN14A
Source: 0000950142-25-000534
Chunk: 1

Company: QXO, Inc.
Filing Date: 2025-02-25
Form: DFAN14A
Chunk 1
---
 per share.

The tender offer, originally set to expire
at 12:00 midnight (New York City time) on February 24, 2025, will remain open until 5:00 p.m. (New York City time) on March 3, 2025. QXO
is currently prepared to complete the acquisition shortly after the tender expires, subject to the offer’s terms. The transaction
is not dependent on any financing or due diligence conditions, and QXO has already obtained antitrust clearance in both the U.S. and Canada.

“Our offer remains the only opportunity
for Beacon shareholders to secure a substantial cash premium now,” said Brad Jacobs, chairman and chief executive officer of QXO.
“We’re confident Beacon investors will overwhelmingly support our offer if the Beacon Board removes its anti-shareholder poison
pill.”

The full terms, conditions and other details of the tender offer are available in the offering documents filed with the Securities and Exchange Commission. To learn more about QXO’s offer and how it benefits Beacon shareholders, visit www.qxo.com/beacon.

Computershare Trust Company, N.A., the depositary and paying agent
for the tender offer, has reported, as of 6:00 p.m. (New York City time) on February 24, 2025, approximately 10,685,631 Shares have been
validly tendered and not withdrawn, representing approximately 17.27% of the issued and outstanding Shares, at that time. Shareholders
who have already tendered their Shares need not take further action in response to this extension. The level of tendered shares is above
expectations, particularly since the Beacon Board has implemented a shareholder-unfriendly poison pill that prevents the tender offer
from closing.

Secured Financing in Place

QXO has secured full financing commitments
from Goldman Sachs, Morgan Stanley, Citi, Crédit Agricole, Wells Fargo and Mizuho. These commitments, combined with QXO’s
cash on hand, fully cover the purchase price, any required refinancing of Beacon’s debt, and associated transaction costs.

Advisors

Morgan Stanley & Co. LLC is acting as lead financial advisor
to QXO, and Paul, Weiss, Rifkind, Wharton & Garrison LLP is acting as legal counsel.

About QXO

QXO provides technology solutions, primarily to clients in the
manufacturing, distribution and service sectors. The company provides consulting and professional services, including specialized